Autoantibody-induced apoptosis as a possible mechanism of autoimmune retinopathy.
about
Circulating anti-retinal antibodies as immune markers in age-related macular degenerationAutoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathyAutoimmune retinopathyCirculating Autoantibodies in Age-Related Macular Degeneration Recognize Human Macular Tissue Antigens Implicated in Autophagy, Immunomodulation, and Protection from Oxidative Stress and ApoptosisOptical coherence tomography findings in autoimmune retinopathy.Anti-γ-enolase autoimmune retinopathy manifesting in early childhood.B Cell Anomalies in Autoimmune Retinopathy (AIR)Cancer-associated retinopathy as the leading symptom in colon cancer.Detection of autoantibodies against heat shock proteins and collapsin response mediator proteins in autoimmune retinopathyLatest updates on antiretinal autoantibodies associated with vision loss and breast cancer.Correlation between Fluorescein Angiographic Findings and Visual Acuity in Behçet Retinal Vasculitis.Immune mechanisms in inflammatory and degenerative eye disease.Cancer-induced, immune-mediated ocular degenerations.The need for standardization of antiretinal antibody detection and measurement.Uveitic foveal atrophy: clinical features and associations.Both systemic and local application of granulocyte-colony stimulating factor (G-CSF) is neuroprotective after retinal ganglion cell axotomy.Autoimmune retinopathy in systemic lupus erythematosus: histopathologic features.Molecular biomarkers for autoimmune retinopathies: significance of anti-transducin-alpha autoantibodies.Significance of Anti-retinal Autoantibodies in Cancer-associated Retinopathy with Gynecological Cancers.Cancer-associated retinopathy with retinal periphlebitis in a patient with ovarian cancer.Autoimmunity and age-related macular degeneration: a review of the literature.Cancer-associated retinopathy: update on pathogenesis and therapy.The immunological basis of degenerative diseases of the eye.Sudden acquired retinal degeneration syndrome (SARDS) - a review and proposed strategies toward a better understanding of pathogenesis, early diagnosis, and therapy.Rituximab as a monotherapy or in combination therapy for the treatment of non-paraneoplastic autoimmune retinopathy.Bilateral paraneoplastic optic neuropathy and unilateral retinal compromise in association with prostate cancer: a differential diagnostic challenge in a patient with unexplained visual lossUnilateral electronegative ERG in a presumed central retinal artery occlusion.Vasoactive neuropeptides in clinical ophthalmology: An association with autoimmune retinopathy?Resuscitation with lactated Ringer solution limits the expression of molecular events associated with lung injury after hemorrhage.Autoimmune Retinopathy: Current Concepts and Practices (An American Ophthalmological Society Thesis).Are Anti-Retinal Autoantibodies a Cause or a Consequence of Retinal Degeneration in Autoimmune Retinopathies?
P2860
Q24682990-CF4E7DD1-8CC8-4E83-A64C-0D87B690024DQ24800667-553A8F94-6FE5-4C81-867B-55211FC67366Q27027058-F5550A76-13E1-4656-93F9-17B8B715757BQ28551885-44C6BD26-BF39-42BD-89EC-550F2062C033Q30423977-D1AFB376-0912-4FEF-AB67-AA2E04BEA4BDQ33768436-A4293144-5670-46C0-8869-BC9B96CC8BDEQ33917237-953DE76E-7BD0-4F75-B2B1-9C3FD9677275Q34513272-55294911-FD33-4AA7-9872-3EBC95856735Q34997655-EC5CBFB7-F884-49C7-8D52-E9183EAAFED3Q35161069-3F53CEAD-8476-4206-8806-65BF380E433BQ35778203-A7167302-4567-4E5E-B394-6DB65927065CQ36040908-EB52D25D-6BB6-42C2-8652-649A72E1427EQ36194825-75149DBC-3871-4E22-BAEE-29635F62AEB8Q36901444-46566E72-C0AE-41A1-8C8C-93544F5AFE0AQ37121919-C35644E5-4326-4E9A-A7C2-2776C42F715CQ37214453-D6BF7F2B-016D-430B-987E-CF297E5377B7Q37239700-1BCD6E06-6C21-4232-ABED-4F8057DCF589Q37438093-96982DAE-EB61-4E20-B013-F85375B52B13Q37657928-D2BA237B-61CA-48DA-8ED6-F614040B385CQ37724791-734FB5AD-6B53-4605-8566-9F034873A1D7Q37940594-76B11AEA-6065-4E57-A695-78DBCBEEF46CQ37940599-A07FA900-771C-49EB-AE02-9FD7CA8BD5F2Q38077553-7803BB4E-3B3C-49B0-ACC0-EEB6445CFEE8Q38533795-7B753F25-C1C1-4403-8BA1-9775933E2C91Q38932153-6A93D263-E4D3-49F3-B68B-8EC6F3E5BBE9Q41398315-71468925-6345-4D2D-B7BD-14F1B202EB00Q41466152-CC1FE504-95C0-4530-A9CD-FA94D0D7A17DQ42063705-474EDBCD-FE45-45C2-A0F9-B2D6F1420E73Q45110778-35123D7C-A4EE-4B5B-A28A-9E3F9E674485Q54968656-926D48B9-1F6C-4058-8A2C-B97F9007C4B1Q55436808-9F0C7B3F-60A2-4AD3-8FA9-9D70D92E181E
P2860
Autoantibody-induced apoptosis as a possible mechanism of autoimmune retinopathy.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Autoantibody-induced apoptosis as a possible mechanism of autoimmune retinopathy.
@ast
Autoantibody-induced apoptosis as a possible mechanism of autoimmune retinopathy.
@en
type
label
Autoantibody-induced apoptosis as a possible mechanism of autoimmune retinopathy.
@ast
Autoantibody-induced apoptosis as a possible mechanism of autoimmune retinopathy.
@en
prefLabel
Autoantibody-induced apoptosis as a possible mechanism of autoimmune retinopathy.
@ast
Autoantibody-induced apoptosis as a possible mechanism of autoimmune retinopathy.
@en
P1433
P1476
Autoantibody-induced apoptosis as a possible mechanism of autoimmune retinopathy.
@en
P2093
Grazyna Adamus
P356
10.1016/S1568-9972(02)00127-1
P577
2003-03-01T00:00:00Z